logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
C

Christiane Pott

University Hospital Schleswig-Holstein
H指数:52
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Trials in progress: CARMAN – study protocol of a randomized controlled, international, multicenter, open-label phase II trial evaluating early treatment intensification in patients with high-risk mantle cell lymphoma using CAR-T-cell treatment after an abbreviated induction therapy with rituximab and ibrutinib and 6 months ibrutinib maintenance as compared to standard of care induction and maintenance

进行中的试验：CARMAN——一项随机对照、国际多中心、开放标签的II期试验研究方案，旨在评估在利妥昔单抗和艾曲波帕缩短期诱导治疗后使用CAR-T细胞治疗进行早期治疗强化，与标准治疗方案诱导和维持治疗相比，在高风险套细胞淋巴瘤患者中的效果。

BMC Cancer
IF3.4
2026-08-110
OAAI
Marie-Kristin Tilch; Christian Schmidt; Marek Trneny; Eva Giné; Olivier Hermine; Anke Ohler; Stephanie Herold; Eva Hoster; Linmiao Jiang; Christiane Pott; Martin Dreyling; Georg Hess
Feasibility and safety of rapid glofitamab ramp-up

快速提升glofitamab的可行性与安全性

Leukemia
IF13.4
2026-07-010
OAAI
Celine H. Liem; Rebecca Wurm-Kuczera; David Böckle; Marie Anne-Catherine Neumann; Marcel Teichert; Urban Novak; Merle Klein Helmkamp; Evgenii Shumilov; Nina Malburg; Tim Versteegen; Fabian Görke; Giulia Magno; Susanne Ghandili; Joseph Kauer; Konstantinos Christofyllakis; Thomas Melchardt; Peter Dreger; Francis Ayuk; Marion Subklewe; Vladan Vučinić; Christiane Pott; Hans Christian Reinhardt; Georg Lenz; Bastian von Tresckow; Thomas Pabst; Peter Borchmann; Antonia Busse; Ulrich Keller; Björn Chapuy
Chemotherapy-free combination of ibrutinib and obinutuzumab for untreated advanced follicular lymphoma: results of a phase II study from the German Lymphoma Alliance (Vol 110, pg 3022, 2025)

化疗-free的ibrutinib与obinutuzumab联合治疗初治性晚期滤泡性淋巴瘤：德国淋巴瘤联盟（Vol 110, pg 3022, 2025）的一项II期研究的结果

HAEMATOLOGICA
IF7.9
2025-12-010
OAAI
Schmidt, Christian; Scheubeck, Gabriel; Jurinovic, Vindi; Soekler, Martin; Forstpointner, Roswitha; Buske, Christian; Viardot, Andreas; Keller, Ulrich; Graeven, Ullrich; Marks, Reinhard; Haenel, Mathias; Liersch, Ruediger; Duerig, Jan; Pott, Christiane; Hoster, Eva; Unterhalt, Michael; Hiddemann, Wolfgang
Chemotherapy-free combination of ibrutinib and obinutuzumab for untreated advanced follicular lymphoma: results of a phase II study from the German Lymphoma Alliance

化疗免联合伊布替尼和奥滨尤妥珠单抗治疗初治晚期滤泡性淋巴瘤：德国淋巴瘤联盟一项II期研究的结果

HAEMATOLOGICA
IF7.9
2025-12-012
OAAI
Schmidt, Christian; Scheubeck, Gabriel; Jurinovic, Vindi; Sokler, Martin; Forstpointner, Roswitha; Buske, Christian; Viardot, Andreas; Keller, Ulrich; Graeven, Ullrich; Marks, Reinhard; Hanel, Mathias; Liersch, Rudiger; Durig, Jan; Pott, Christiane; Hoster, Eva; Unterhalt, Michael; Hiddemann, Wolfgang
Noninvasive genotyping and early disease dynamics demonstrate the efficacy of ibrutinib in combination with immunochemotherapy in patients with mantle cell lymphoma treated in the TRIANGLE trial

非侵入性基因分型及早期疾病动态变化表明，在TRIANGLE试验中接受治疗的套细胞淋巴瘤患者中，伊布替尼联合免疫化疗的疗效。

Leukemia
IF13.4
2025-11-030
OAAI
Mouhamad Khouja; Elisa Genuardi; Simone Ferrero; Anna Laqua; Beatrice Alessandria; Onno J. H. M. Verhagen; Christa H. E. Homburg; Ramón García Sanz; Alejandro Medina Herrera; Vincent H. J. van der Velden; Maria Gomes da Silva; Paula Gameiro; Jeanette Doorduijn; Eva Giné; Carlo Visco; Monika Brüggemann; Claudia D. Baldus; Marco Ladetto; Christian Schmidt; Martin Dreyling; Linmiao Jiang; Eva Hoster; Nikos Darzentas; Karol Pal; Guranda Chitadze; James Peter Stewart; David Gonzalez; Christiane Pott
ctDNA dynamics demonstrates rapid treatment response to tafasitamab + R-CHOP +/− lenalidomide and predicts outcome in diffuse large B-cell lymphoma: results from the phase 1b First-MIND study

ctDNA动力学证明了tafasitamab + R-CHOP +/- lenalidomide的快速治疗反应，并能预测弥漫性大B细胞淋巴瘤的结局：First-MIND 1b期研究结果

Leukemia
IF13.4
2025-10-270
OA
Mouhamad Khouja; Britta Kehden; Derek Blair; Christian Kuffer; Steve Wagner; Tim Versteegen; Philipp Nakov; Monika Brüggemann; Claudia Baldus; David Belada; Grzegorz S. Nowakowski; Anke Schilhabel; Nikos Darzentas; Christiane Pott
The MCL elderly III trial protocol: an international, randomized, open-label phase II trial to investigate the combinations of venetoclax, ibrutinib and rituximab or bendamustine, ibrutinib and rituximab in patients with treatment naive mantle cell lymphoma not eligible for dose-intensive treatment

MCL elderly III临床试验方案：一项国际性、随机化、开放标签的II期临床试验，旨在研究在初治且不适合剂量密集型治疗的外周细胞淋巴瘤患者中，评估venetoclax、ibrutinib和rituximab或bendamustine、ibrutinib和rituximab的联合治疗方案。

BMC Cancer
IF3.4
2025-08-290
OAAI
Stephanie Herold; Christian Schmidt; Carlo Visco; Marie-Kristin Tilch; Anke Ohler; Michael Unterhalt; Eva Hoster; Elisabeth Hoenig; Susanne Singer; Alessandra Tucci; Christiane Pott; Marco Ladetto; Georg Hess; Martin Dreyling
Outcomes of bispecific antibody therapy after CAR T-cell failure in relapsed/refractory large B-cell lymphoma

双特异性抗体疗法在复发/难治性大B细胞淋巴瘤中CAR T细胞治疗失败后的疗效

Blood Advances
IF7.1
2025-04-190
OA
Evgenii Shumilov; Julia Katharina Scholz; Maximilian Seib; Paolo Mazzeo; Rebecca Wurm-Kuczera; Vladan Vucinic; Udo Holtick; Hristo Boyadzhiev; Thomas Melchardt; Alexander Hölscher; Christian Schultze-Florey; Atef Abdelhafez; Giuliano Filippini Velazquez; Anna Ossami Saidy; Vadim Lesan; Ulf Schnetzke; Andrea Kerkhoff; Ulrike Bacher; Susanne Ghandili; Enver Aydilek; Niklas Gebauer; Thomas Weber; Gerald Wulf; Bertram Glass; Lorenz Thurner; Florian H. Heidel; Christoph Schmid; Andreas Viardot; Mathias Hänel; Sascha Dietrich; Thomas Pabst; Francis Ayuk; Bastian von Tresckow; Björn Chapuy; Christiane Pott; Fabian Müller; Georg Lenz
NGS-based IG/TR gene rearrangement profiling in acute lymphoblastic leukemia: age dependence of immunogenetic maturation

基于NGS的IG/TR基因重排分析在急性淋巴细胞白血病中的应用：免疫遗传学成熟的年龄依赖性

Blood
IF23.1
2025-03-270
PREAI
Michaela Kotrová; Constantin Proske; Nikos Darzentas; Anna Laqua; Britta Kehden; Jan Kässens; Sonja Bendig; Saskia Kohlscheen; Monika Szczepanowski; Wiebke Wessels; Željko Antic; Christiane Pott; Matthias Ritgen; Jacques J. M. van Dongen; Nicola Gökbuget; Guranda Chitadze; Anke Bergmann; Lorenz Bastian; Claudia D. Baldus; Gunnar Cario; Martin Schrappe; Stefan Schwartz; Julia Alten; Rolf Köhler; Monika Brüggemann
Determining the Mutational Landscape of Waldenstrom's Macroglobulinemia By Liquid Biopsy: Results of the Prospective Ecwm-2 Trial of the European Consortium for Waldenstrom's Macroglobulinemia

通过液体活检确定华氏巨球蛋白血症的突变景观：欧洲华氏巨球蛋白血症联盟前瞻性Ecwm-2试验的结果

BLOOD
IF23.1
2024-11-050
PRE
Nakov, Philipp; Drandi, Daniela; Kaiser, Lisa Marie; Kaszynski, Dajana; Grunenberg, Alexander; Mark, Jasmin; Runge, Elke; Dimopoulos, Meletios; Kastritis, Efstathios; Bagratuni, Tina; Buske, Christian; Pott, Christiane; Ferrero, Simone; Khouja, Mouhamad
Time of CAR-T Failure Is a Strong Predictor of Outcome for Bispecific Antibody Therapy in Relapsed/Refractory Large B-Cell Lymphoma

CAR-T失败时间是对复发/难治性大B细胞淋巴瘤双特异性抗体疗法结局的强预测因子

BLOOD
IF23.1
2024-11-051
PRE
Shumilov, Evgenii; Wurm-Kuczera, Rebecca; Vucinic, Vladan; Seib, Maximilian; Holtick, Udo; Mazzeo, Paolo; Scholz, Julia Katharina; Boyadzhiev, Hristo; Melchardt, Thomas; Hoelscher, Alexander; Schultze-Florey, Christian R.; Velazquez, Giuliano Filippini; Saidy, Anna Ossami; Lesan, Vadim; Schnetzke, Ulf; Kerkhoff, Andrea; Bacher, Ulrike; Ghandili, Susanne; Aydilek, Enver; Gebauer, Niklas; Weber, Thomas; Wulf, Gerald; Glass, Bertram; Thurner, Lorenz; Heidel, Florian; Schmid, Christoph; Viardot, Andreas; Haenel, Mathias; Dietrich, Sascha; Pabst, Thomas; Ayuk, Francis A.; von Tresckow, Bastian; Chapuy, Bjorn; Pott, Christiane; Mueller, Fabian; Lenz, Georg
Impact of Rituximab Maintenance Added to Ibrutinib-Containing Regimens with and without ASCT in Younger, Previously Untreated MCL Patients: An Analysis of the Triangle Data Embedded in the Multiply Project

利妥昔单抗维持治疗联合含伊布替尼方案（含或不含ASCT）对年轻、初治套细胞淋巴瘤患者的影响：一项来自Multiply项目嵌入Triangle数据集的分析

BLOOD
IF23.1
2024-11-053
PRE
Ladetto, Marco; Gutmair, Katja; Doorduijn, Jeanette K.; Gine, Eva; Jerkeman, Mats; Walewski, Jan; Hutchings, Martin; Mey, Ulrich; Riise, Jon; Trneny, Marek; Vergote, Vibeke K. J.; Stefani, Piero Maria; Horowitz, Netanel A.; da Silva, Maria Gomes; Leppa, Sirpa; Jiang, Linmiao; Pott, Christiane; Klapper, Wolfram; Schmidt, Christian; Unterhalt, Michael; Dreyling, Martin; Hoster, Eva
Role of Autologous Stem Cell Transplantation in the Context of Ibrutinib-Containing First-Line Treatment in Younger Patients with Mantle Cell Lymphoma: Results from the Randomized Triangle Trial By the European MCL Network

自体干细胞移植在含伊布替尼的一线治疗背景下年轻套细胞淋巴瘤患者中的作用：欧洲MCL网络随机Triangle试验结果

BLOOD
IF23.1
2024-11-051
PRE
Dreyling, Martin; Doorduijn, Jeanette K.; Gine, Eva; Jerkeman, Mats; Walewski, Jan; Hutchings, Martin; Mey, Ulrich; Riise, Jon; Trneny, Marek; Vergote, Vibeke K. J.; Donnarumma, Daniela; Shpilberg, Ofer; da Silva, Maria Gomes; Leppa, Sirpa; Jiang, Linmiao; Pott, Christiane; Klapper, Wolfram; Schmidt, Christian; Unterhalt, Michael; Ladetto, Marco; Hoster, Eva
The gray area of RQ-PCR-based measurable residual disease: subdividing the positive, below quantitative range category
LEUKEMIA
IF13.4
2024-05-173
OAAI
Kotrova, Michaela; Fronkova, Eva; Svaton, Michael; Drandi, Daniela; Schoen, Felix; Hoogeveen, Patricia; Hancock, Jeremy; Skotnicova, Aneta; Schilhabel, Anke; Eckert, Cornelia; Clappier, Emmanuelle; Cazzaniga, Gianni; Schaefer, Beat W.; van Dongen, Jacques J. M.; Ritgen, Matthias; Pott, Christiane; van der Velden, Vincent H. J.; Trka, Jan; Brueggemann, Monika

研究方向

暂未获取到该数据
E
Eva Hoster
H 指数:53论文数:263被引数:1.1万
W
Wolfram Klapper
H 指数:104论文数:773被引数:4.9万
M
Martin Dreyling
H 指数:83论文数:706被引数:3.2万
M
Monika Brüggemann
H 指数:10论文数:44被引数:428
M
Matthias Ritgen
H 指数:52论文数:286被引数:1.6万
M
Michael Unterhalt
H 指数:49论文数:297被引数:1.0万
M
Marco Ladetto
H 指数:66论文数:508被引数:1.5万
M
Michael Kneba
H 指数:94论文数:576被引数:4.7万
C
Christian Schmidt
H 指数:40论文数:402被引数:6,510
M
Martin Dreyling
H 指数:27论文数:196被引数:3,130